I’m excited to share my executive biography, highlighting more than 27 years of experience leading commercial strategy, market access, healthcare reimbursement, and pharmaceutical commercialization across the biopharmaceutical, healthcare, and life sciences industries. Throughout my career, I have been passionate about helping innovative therapies reach patients while building high-performing organizations and creating sustainable commercial success. As I continue pursuing corporate board opportunities, I look forward to contributing my expertise in commercialization, reimbursement strategy, healthcare finance, and executive leadership to organizations committed to innovation and improving patient outcomes.

I’m excited to share my executive biography, which reflects my 25+ year journey in pharmaceutical, biotechnology, and clinical operations leadership. Throughout my career, I’ve been passionate about helping organizations translate clinical strategy into operational excellence, improving global trial execution, and expanding patient access to innovative therapies. I’m grateful for the opportunity to collaborate with exceptional teams and look forward to continuing to serve organizations through executive leadership, advisory work, and board service.

After over two decades in pharmaceutical marketing, I’ve had the privilege to lead, build, and grow brands that have made a real difference in patients' lives. From training and launching field sales teams to guiding strategic brand transformations at Amgen and Horizon, the journey has been deeply rewarding. Here is my biography.

Mary Hames is a seasoned Medical Affairs executive with a proven track record of leading high-performing teams and delivering strategic impact across rare disease, diagnostics, and oncology. With a foundation in biochemical genetics and over a decade of industry experience, she has played pivotal roles in clinical operations, launch preparedness, and cross-functional leadership. Known for her ability to navigate complex medical landscapes, Mary has successfully built and led medical teams, advanced companion diagnostics, and driven field strategy across multiple therapeutic areas. Her leadership is marked by scientific rigor, operational excellence, and a deep commitment to improving outcomes for patients with rare and life-threatening conditions.

Excited to share my professional biography, highlighting my journey in global strategy, product launches, and commercialization within the pharmaceutical and biotech sectors. With over 25 years of experience, I've had the opportunity to work with extraordinary teams, driving growth and innovation across complex therapeutic areas. Here is my biography.